HK Stock MarketDetailed Quotes

02407 GAUSH MEDITECH

Watchlist

17.360
-1.180-6.36%

Market Closed May 31 16:08 CST

2.57BMarket Cap13.42P/E (TTM)

GAUSH MEDITECH Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

Turnover

12.16%1.41B

21.26%700.7M

-3.42%1.25B

-0.12%577.87M

34.94%1.3B

66.20%578.57M

-13.06%962.08M

--348.11M

19.43%1.11B

--926.59M

Operating income

12.16%1.41B

21.26%700.7M

-3.42%1.25B

-0.12%577.87M

34.94%1.3B

66.20%578.57M

-13.06%962.08M

348.11M

19.43%1.11B

926.59M

Cost of sales

-13.71%-714.64M

-16.34%-345.1M

8.76%-628.45M

3.93%-296.63M

-30.97%-688.75M

-61.06%-308.77M

18.25%-525.9M

---191.71M

-17.42%-643.31M

---547.85M

Operating expenses

-13.71%-714.64M

-16.34%-345.1M

8.76%-628.45M

3.93%-296.63M

-30.97%-688.75M

-61.06%-308.77M

18.25%-525.9M

-191.71M

-17.42%-643.31M

-547.85M

Gross profit

10.60%691.6M

26.44%355.61M

2.60%625.34M

4.24%281.24M

39.73%609.47M

72.50%269.8M

-5.86%436.18M

156.4M

22.34%463.35M

378.73M

Selling expenses

-32.52%-248.83M

-34.14%-120.89M

0.90%-187.77M

-6.92%-90.12M

-17.84%-189.47M

-32.57%-84.29M

19.81%-160.79M

---63.58M

-3.13%-200.52M

---194.43M

Administrative expenses

11.48%-129.38M

10.41%-62.53M

-11.14%-146.17M

-18.47%-69.79M

-45.96%-131.52M

-119.00%-58.91M

-14.87%-90.11M

---26.9M

-12.73%-78.44M

---69.59M

Research and development expenses

-28.70%-52.88M

-16.46%-26.11M

-74.80%-41.09M

-138.98%-22.42M

-648.84%-23.51M

-546.01%-9.38M

-18.05%-3.14M

---1.45M

-12.81%-2.66M

---2.36M

Revaluation surplus

----

18.15%-307.43M

63.63%-36.1M

-481.15%-375.61M

---99.25M

62.67%-64.63M

----

---173.15M

----

-Changes in the fair value of other assets

----

18.15%-307.43M

63.63%-36.1M

-481.15%-375.61M

---99.25M

62.67%-64.63M

----

---173.15M

----

Special items of operating profit

121.58%37.84M

126.69%19.82M

-411.96%-175.3M

-339.65%-74.26M

61.84%56.19M

185.38%30.99M

1,196.68%34.72M

---36.3M

97.40%-3.17M

---121.79M

Operating profit

228.37%298.34M

1,549.27%165.91M

-326.92%-232.41M

-123.38%-11.45M

-135.76%-54.44M

73.75%48.96M

2,714.92%152.23M

28.18M

157.35%5.41M

-9.43M

Financing cost

-18.57%-50.61M

-14.42%-23.68M

48.90%-42.68M

65.77%-20.7M

-2,615.38%-83.53M

-9,606.58%-60.47M

5.62%-3.08M

---623K

-6.54%-3.26M

---3.06M

Earning before tax

190.05%247.74M

542.43%142.23M

-99.40%-275.09M

-179.25%-32.15M

-192.50%-137.96M

-141.78%-11.51M

6,840.67%149.16M

27.56M

117.21%2.15M

-12.49M

Tax

3.60%-74.82M

-50.63%-31.81M

-44.79%-77.62M

8.48%-21.12M

-5.91%-53.61M

-57.65%-23.07M

-25.99%-50.62M

---14.64M

-53.83%-40.18M

---26.12M

After-tax profit from continuing operations

149.02%172.91M

307.31%110.42M

-84.12%-352.71M

-54.01%-53.26M

-294.41%-191.57M

-367.69%-34.59M

359.13%98.54M

12.92M

1.50%-38.03M

-38.61M

Earning after tax

149.02%172.91M

307.31%110.42M

-84.12%-352.71M

-54.01%-53.26M

-294.41%-191.57M

-367.69%-34.59M

359.13%98.54M

12.92M

1.50%-38.03M

-38.61M

Minority profit

80.31%-609K

58.92%-875K

-175.18%-3.09M

-1,631.71%-2.13M

-35.59%-1.12M

67.11%-123K

15.84%-829K

---374K

18.73%-985K

---1.21M

Profit attributable to shareholders

149.63%173.52M

317.66%111.3M

-83.58%-349.62M

-48.38%-51.13M

-291.66%-190.45M

-359.23%-34.46M

368.26%99.37M

13.29M

0.94%-37.04M

-37.39M

Basic earnings per share

132.41%1.17

238.89%0.75

-81.41%-3.61

-58.82%-0.54

-311.70%-1.99

-361.54%-0.34

376.47%0.94

0.13

0.00%-0.34

-0.34

Diluted earnings per share

0.75

-361.54%-0.34

376.47%0.94

0.13

0.00%-0.34

-0.34

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018
Turnover	12.16%1.41B	21.26%700.7M	-3.42%1.25B	-0.12%577.87M	34.94%1.3B	66.20%578.57M	-13.06%962.08M	--348.11M	19.43%1.11B	--926.59M
Operating income	12.16%1.41B	21.26%700.7M	-3.42%1.25B	-0.12%577.87M	34.94%1.3B	66.20%578.57M	-13.06%962.08M	348.11M	19.43%1.11B	926.59M
Cost of sales	-13.71%-714.64M	-16.34%-345.1M	8.76%-628.45M	3.93%-296.63M	-30.97%-688.75M	-61.06%-308.77M	18.25%-525.9M	---191.71M	-17.42%-643.31M	---547.85M
Operating expenses	-13.71%-714.64M	-16.34%-345.1M	8.76%-628.45M	3.93%-296.63M	-30.97%-688.75M	-61.06%-308.77M	18.25%-525.9M	-191.71M	-17.42%-643.31M	-547.85M
Gross profit	10.60%691.6M	26.44%355.61M	2.60%625.34M	4.24%281.24M	39.73%609.47M	72.50%269.8M	-5.86%436.18M	156.4M	22.34%463.35M	378.73M
Selling expenses	-32.52%-248.83M	-34.14%-120.89M	0.90%-187.77M	-6.92%-90.12M	-17.84%-189.47M	-32.57%-84.29M	19.81%-160.79M	---63.58M	-3.13%-200.52M	---194.43M
Administrative expenses	11.48%-129.38M	10.41%-62.53M	-11.14%-146.17M	-18.47%-69.79M	-45.96%-131.52M	-119.00%-58.91M	-14.87%-90.11M	---26.9M	-12.73%-78.44M	---69.59M
Research and development expenses	-28.70%-52.88M	-16.46%-26.11M	-74.80%-41.09M	-138.98%-22.42M	-648.84%-23.51M	-546.01%-9.38M	-18.05%-3.14M	---1.45M	-12.81%-2.66M	---2.36M
Revaluation surplus	----	----	18.15%-307.43M	63.63%-36.1M	-481.15%-375.61M	---99.25M	62.67%-64.63M	----	---173.15M	----
-Changes in the fair value of other assets	----	----	18.15%-307.43M	63.63%-36.1M	-481.15%-375.61M	---99.25M	62.67%-64.63M	----	---173.15M	----
Special items of operating profit	121.58%37.84M	126.69%19.82M	-411.96%-175.3M	-339.65%-74.26M	61.84%56.19M	185.38%30.99M	1,196.68%34.72M	---36.3M	97.40%-3.17M	---121.79M
Operating profit	228.37%298.34M	1,549.27%165.91M	-326.92%-232.41M	-123.38%-11.45M	-135.76%-54.44M	73.75%48.96M	2,714.92%152.23M	28.18M	157.35%5.41M	-9.43M
Financing cost	-18.57%-50.61M	-14.42%-23.68M	48.90%-42.68M	65.77%-20.7M	-2,615.38%-83.53M	-9,606.58%-60.47M	5.62%-3.08M	---623K	-6.54%-3.26M	---3.06M
Earning before tax	190.05%247.74M	542.43%142.23M	-99.40%-275.09M	-179.25%-32.15M	-192.50%-137.96M	-141.78%-11.51M	6,840.67%149.16M	27.56M	117.21%2.15M	-12.49M
Tax	3.60%-74.82M	-50.63%-31.81M	-44.79%-77.62M	8.48%-21.12M	-5.91%-53.61M	-57.65%-23.07M	-25.99%-50.62M	---14.64M	-53.83%-40.18M	---26.12M
After-tax profit from continuing operations	149.02%172.91M	307.31%110.42M	-84.12%-352.71M	-54.01%-53.26M	-294.41%-191.57M	-367.69%-34.59M	359.13%98.54M	12.92M	1.50%-38.03M	-38.61M
Earning after tax	149.02%172.91M	307.31%110.42M	-84.12%-352.71M	-54.01%-53.26M	-294.41%-191.57M	-367.69%-34.59M	359.13%98.54M	12.92M	1.50%-38.03M	-38.61M
Minority profit	80.31%-609K	58.92%-875K	-175.18%-3.09M	-1,631.71%-2.13M	-35.59%-1.12M	67.11%-123K	15.84%-829K	---374K	18.73%-985K	---1.21M
Profit attributable to shareholders	149.63%173.52M	317.66%111.3M	-83.58%-349.62M	-48.38%-51.13M	-291.66%-190.45M	-359.23%-34.46M	368.26%99.37M	13.29M	0.94%-37.04M	-37.39M
Basic earnings per share	132.41%1.17	238.89%0.75	-81.41%-3.61	-58.82%-0.54	-311.70%-1.99	-361.54%-0.34	376.47%0.94	0.13	0.00%-0.34	-0.34
Diluted earnings per share		0.75				-361.54%-0.34	376.47%0.94	0.13	0.00%-0.34	-0.34
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

02407 GAUSH MEDITECH

GAUSH MEDITECH Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target